questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines et peptides de signalisation intracellulaire
Protein-Serine-Threonine Kinases
Cyclic Nucleotide-Regulated Protein Kinases
Cyclic GMP-Dependent Protein Kinases
Cyclic GMP-Dependent Protein Kinases : Questions médicales fréquentes
Termes MeSH sélectionnés :
Sensitivity and Specificity
Diagnostic
5
GMP cyclique
Tests de laboratoire
Kinases
Essais enzymatiques
Symptômes
5
Troubles neurologiques
Kinases
Fonction cardiaque
Kinases
Maladies cardiovasculaires
Kinases
Troubles de l'humeur
Kinases
Traitements
5
Thérapies géniques
Kinases
Plantes médicinales
Kinases
Complications
5
Troubles de la coagulation
Kinases
Troubles respiratoires
Kinases
Facteurs de risque
5
Facteurs de risque
Kinases
Antécédents familiaux
Kinases
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-Dependent Protein Kinases : Questions médicales les plus fréquentes",
"headline": "Cyclic GMP-Dependent Protein Kinases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cyclic GMP-Dependent Protein Kinases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-11",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-Dependent Protein Kinases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"url": "https://questionsmedicales.fr/mesh/D017867",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D017867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-dependent protein kinase type I",
"alternateName": "Cyclic GMP-Dependent Protein Kinase Type I",
"url": "https://questionsmedicales.fr/mesh/D062965",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-dependent protein kinase type I",
"code": {
"@type": "MedicalCode",
"code": "D062965",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150.150.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cyclic GMP-dependent protein kinase type II",
"alternateName": "Cyclic GMP-Dependent Protein Kinase Type II",
"url": "https://questionsmedicales.fr/mesh/D062967",
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-dependent protein kinase type II",
"code": {
"@type": "MedicalCode",
"code": "D062967",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.476.563.150.150.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Cyclic GMP-Dependent Protein Kinases",
"alternateName": "Cyclic GMP-Dependent Protein Kinases",
"code": {
"@type": "MedicalCode",
"code": "D017869",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fengyang Li",
"url": "https://questionsmedicales.fr/author/Fengyang%20Li",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ute Römling",
"url": "https://questionsmedicales.fr/author/Ute%20R%C3%B6mling",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Stepan Gambaryan",
"url": "https://questionsmedicales.fr/author/Stepan%20Gambaryan",
"affiliation": {
"@type": "Organization",
"name": "Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Saint Petersburg 194223, Russia."
}
},
{
"@type": "Person",
"name": "Roshni R Kharadi",
"url": "https://questionsmedicales.fr/author/Roshni%20R%20Kharadi",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA."
}
},
{
"@type": "Person",
"name": "George W Sundin",
"url": "https://questionsmedicales.fr/author/George%20W%20Sundin",
"affiliation": {
"@type": "Organization",
"name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "AUCReshaping: improved sensitivity at high-specificity.",
"datePublished": "2023-11-30",
"url": "https://questionsmedicales.fr/article/38036602",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-48482-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "Meta-analysis assessing the sensitivity and specificity of",
"datePublished": "2023-03-18",
"url": "https://questionsmedicales.fr/article/36934977",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ahj.2023.03.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sensitivity and specificity of Varian Halcyon's portal dosimetry for plan-specific pre-treatment QA.",
"datePublished": "2023-04-22",
"url": "https://questionsmedicales.fr/article/37086428",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acm2.14001"
}
},
{
"@type": "ScholarlyArticle",
"name": "Specific recognition and sensitive quantification of mRNA splice variants",
"datePublished": "2023-11-06",
"url": "https://questionsmedicales.fr/article/37818948",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d3an01382k"
}
},
{
"@type": "ScholarlyArticle",
"name": "Estimating stage-specific sensitivity for cancer screening tests.",
"datePublished": "2023-02-03",
"url": "https://questionsmedicales.fr/article/36734139",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/09691413231154801"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines et peptides de signalisation intracellulaire",
"item": "https://questionsmedicales.fr/mesh/D047908"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protein-Serine-Threonine Kinases",
"item": "https://questionsmedicales.fr/mesh/D017346"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cyclic Nucleotide-Regulated Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D017867"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cyclic GMP-Dependent Protein Kinases",
"item": "https://questionsmedicales.fr/mesh/D017869"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cyclic GMP-Dependent Protein Kinases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cyclic GMP-Dependent Protein Kinases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cyclic GMP-Dependent Protein Kinases",
"description": "Comment diagnostiquer une dysfonction des kinases cGMP ?\nQuels tests sont utilisés pour mesurer le cGMP ?\nQuels symptômes indiquent un problème avec les kinases cGMP ?\nLes tests génétiques sont-ils utiles pour les kinases cGMP ?\nComment évaluer l'activité des kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Sensitivity+and+Specificity#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels sont les symptômes d'une déficience en kinases cGMP ?\nLes troubles neurologiques sont-ils liés aux kinases cGMP ?\nComment les kinases cGMP affectent-elles la fonction cardiaque ?\nY a-t-il des symptômes spécifiques aux maladies liées aux kinases cGMP ?\nLes troubles de l'humeur peuvent-ils être liés aux kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Sensitivity+and+Specificity#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cyclic GMP-Dependent Protein Kinases",
"description": "Comment prévenir les troubles liés aux kinases cGMP ?\nL'alimentation influence-t-elle les kinases cGMP ?\nLe stress a-t-il un impact sur les kinases cGMP ?\nLes examens réguliers sont-ils importants ?\nL'exercice physique aide-t-il à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Sensitivity+and+Specificity#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels traitements ciblent les kinases cGMP ?\nLes médicaments augmentant le cGMP sont-ils efficaces ?\nComment les thérapies géniques peuvent-elles aider ?\nY a-t-il des traitements naturels pour les dysfonctionnements cGMP ?\nLes changements de mode de vie peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Sensitivity+and+Specificity#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quelles complications peuvent survenir avec des dysfonctionnements cGMP ?\nLes troubles de la coagulation sont-ils liés aux kinases cGMP ?\nY a-t-il des risques de cancer associés aux kinases cGMP ?\nLes maladies rénales peuvent-elles être influencées par cGMP ?\nLes troubles respiratoires sont-ils liés aux kinases cGMP ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Sensitivity+and+Specificity#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cyclic GMP-Dependent Protein Kinases",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements cGMP ?\nL'âge influence-t-il la fonction des kinases cGMP ?\nLe mode de vie sédentaire est-il un facteur de risque ?\nLe stress chronique est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D017869?mesh_terms=Sensitivity+and+Specificity#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des kinases cGMP ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests biochimiques et des analyses génétiques peuvent être utilisés pour évaluer la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour mesurer le cGMP ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des dosages immunologiques et des tests enzymatiques peuvent mesurer les niveaux de cGMP dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les kinases cGMP ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes variés comme des troubles cardiovasculaires ou neurologiques peuvent indiquer un dysfonctionnement."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les kinases cGMP ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations affectant les kinases cGMP."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'activité des kinases cGMP ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'activité peut être évaluée par des essais enzymatiques spécifiques in vitro."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en kinases cGMP ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des troubles de la circulation sanguine et des problèmes de vision."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils liés aux kinases cGMP ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les kinases cGMP peuvent contribuer à des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Comment les kinases cGMP affectent-elles la fonction cardiaque ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles régulent la relaxation et la contraction cardiaque, influençant la pression artérielle."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux maladies liées aux kinases cGMP ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes spécifiques peuvent inclure des douleurs thoraciques et des palpitations."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur peuvent-ils être liés aux kinases cGMP ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des études suggèrent un lien entre les kinases cGMP et la régulation de l'humeur."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux kinases cGMP ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie sain et surveiller les facteurs de risque cardiovasculaires aide à prévenir."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle les kinases cGMP ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en antioxydants peut soutenir la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur les kinases cGMP ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut affecter la signalisation cGMP et la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des dysfonctionnements cGMP."
}
},
{
"@type": "Question",
"name": "L'exercice physique aide-t-il à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la signalisation cGMP et la santé globale."
}
},
{
"@type": "Question",
"name": "Quels traitements ciblent les kinases cGMP ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des inhibiteurs spécifiques et des modulateurs de cGMP sont utilisés pour traiter certaines conditions."
}
},
{
"@type": "Question",
"name": "Les médicaments augmentant le cGMP sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme les nitrates et les inhibiteurs de la phosphodiestérase peuvent être efficaces."
}
},
{
"@type": "Question",
"name": "Comment les thérapies géniques peuvent-elles aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies géniques peuvent corriger des mutations dans les gènes des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour les dysfonctionnements cGMP ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines plantes médicinales peuvent avoir des effets bénéfiques sur la signalisation cGMP."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation saine et l'exercice peuvent améliorer la fonction des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des dysfonctionnements cGMP ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications peuvent inclure des maladies cardiovasculaires et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les troubles de la coagulation sont-ils liés aux kinases cGMP ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans les kinases cGMP peuvent affecter la coagulation sanguine."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés aux kinases cGMP ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les dysfonctionnements cGMP et le développement du cancer."
}
},
{
"@type": "Question",
"name": "Les maladies rénales peuvent-elles être influencées par cGMP ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les kinases cGMP jouent un rôle dans la régulation de la fonction rénale."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires sont-ils liés aux kinases cGMP ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans la signalisation cGMP peuvent contribuer à des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements cGMP ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hypertension, le diabète et le tabagisme."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la fonction des kinases cGMP ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut affecter la signalisation cGMP et la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Le mode de vie sédentaire est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire peut augmenter le risque de dysfonctionnement des kinases cGMP."
}
},
{
"@type": "Question",
"name": "Le stress chronique est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber la signalisation cGMP et augmenter les risques de maladies."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies cardiovasculaires peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 06/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
3 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Saint Petersburg 194223, Russia.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, Michigan, USA.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular and Cellular Biology, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Veterinary Clinical Pathology and Bio-safety Research Institute, College of Veterinary Medicine, Chonbuk National University, Jeonju, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular and Cellular Biology, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
BK21Plus Program for 21st Century Biomedical Science Leader Development, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
2 publications dans cette catégorie
Publications dans "Cyclic GMP-Dependent Protein Kinases" :
The evaluation of deep-learning (DL) systems typically relies on the Area under the Receiver-Operating-Curve (AU-ROC) as a performance metric. However, AU-ROC, in its holistic form, does not sufficien...
The use of...
To estimate the summary sensitivity and specificity of...
Studies were included if PET/CT was performed for suspicion of PVE and IPD of both the PET/CT result and final diagnosis defined by a gold-standard assessment was available. There were 3 possible fina...
Seventeen studies were included with IPD available for 537 patients (from 538 scans). The summary sensitivity and specificity were 85% (95% CI 74.2%-91.8%) and 86.5% (95% CI 75.8%-92.9%) respectively ...
Developed as a plan-specific pre-treatment QA tool, Varian portal dosimetry promises a fast, high-resolution, and integrated QA solution. In this study, the agreement between predicted fluence and mea...
All patient plans and the corresponding verification plans were generated within the Eclipse treatment planning system. Four representative plans of different treatment sites (prostate, prostate with ...
Predicted and acquired portal dosimetry fluences demonstrated a high agreement evident by average gamma passing rates for the clinical patient plans of 99.90%, 96.64%, and 91.87% for γ...
Owing to the high achievable spatial resolution, portal dosimetry at the Halcyon can reliably be deployed as plan-specific pre-treatment QA tool to screen for errors. It is recommended to support the ...
Specific recognition and sensitive quantification of mRNA alternative splice variants have been a necessity for exploring the regulatory mechanism of RNA splicing and revealing the association between...
When evaluating potential new cancer screening modalities, estimating sensitivity, especially for early-stage cases, is critical. There are methods to approximate stage-specific sensitivity in asympto...
We fit natural history models to lung and ovarian cancer screening data that permitted estimation of stage-specific (early/late) true sensitivity, defined as the probability subjects screened in the g...
Stage-specific true sensitivities estimated by the lung cancer natural history model were 47% (early) and 63% (late). Simulation results for the prospective setting gave estimated sensitivities of 81%...
Existing methods for approximating stage-specific sensitivity in both prospective and retrospective scenarios are unsatisfactory; improvements are needed before they can be considered to be reliable....
Recombinant proteins in complex solutions are typically detected with tag-specific antibodies in Western blots. Here we describe an antibody-free alternative in which tagged proteins are detected dire...
Children with cancer often present with general and nonspecific symptoms leading to initial diagnostic workup inclusive of clinical imaging. Various sequences of magnetic resonance imaging (MRI) are b...
Enzyme-linked immunosorbent assays (ELISAs) are a cornerstone of modern molecular detection, but the technique still faces notable challenges. One of the biggest problems is discriminating true signal...
To evaluate the sensitivity and specificity of the ABCD progression display for keratoconus progression....
Data was collected from patients that underwent at least two Pentacam assessments 6 months apart. Sensitivity and specificity were calculated for the ABCD progression display. Progression was defined ...
Thirty eyes were evaluated over a median time of 10.3 months. Progression by criterion 1 resulted in a sensitivity of 61.9% and specificity of 88.9%. Progression by criterion 2 resulted in higher sens...
The ABCD progression display can assess keratoconus progression with high sensitivity and specificity, thus assisting the patients' decision-making process. The D parameter did not contribute to the s...
To systematically evaluate the evidence for the reliability, sensitivity and specificity of existing measures of vowel-initial voice onset....
A literature search was conducted across electronic databases for published studies (MEDLINE, EMBASE, Scopus, Web of Science, CINAHL, PubMed Central, IEEE Xplore) and grey literature (ProQuest for unp...
The search retrieved 6,983 records. Titles and abstracts were screened against the inclusion criteria by two independent reviewers, with a third reviewer responsible for conflict resolution. Thirty-fi...
A range of vowel-initial voice onset measurements have been applied throughout the literature, however, there is a lack of evidence regarding their sensitivity, specificity and reliability in the dete...